BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2021
View Archived Issues
BeiGene initiates first-in-human trial of BGB-15025
Read More
FDA clears IND application for PhageBank as treatment of prosthetic joint infections
Read More
Lilly reports promising data from new phase III cohort of BLAZE-1 study in early COVID-19
Read More
FDA clears IND for izokibep as treatment of noninfectious nonanterior uveitis
Read More
CROI 2021: Sending HIV into the gene desert could be path to functional cure
Read More
Millendo Therapeutics patents tachykinin NK3 receptor antagonists
Read More
Bristol Myers Squibb discloses new IRAK-4 inhibitors
Read More
Dr Reddy's Institute of Life Sciences patents 5-HT2C receptor PAAMs
Read More
Novartis identifies new NSD2 inhibitors
Read More
Maavrx patents TH- and GCH1-encoding genetic constructs for PD
Read More
DemeRx receives approval for phase I/II study of ibogaine in the U.K.
Read More
Adicet Bio initiates first-in-human phase I trial of ADI-001
Read More
Modus Therapeutics to initiate clinical development of sevuparin in sepsis and septic shock
Read More
Dosing initiates in first-in-human study of IMP-7068 in advanced solid tumors
Read More
IDMC recommends stopping phase III COMET-ICE trial of VIR-7831 early for efficacy
Read More
Topline phase II data on C-21 in patients with systemic sclerosis and Raynaud's phenomenon
Read More
Injectable hydrogel with MSN/microRNA-21-5p complexes reduces infarct size in vivo
Read More
FDA approves Fotivda for relapsed or refractory advanced RCC
Read More
NU-9, the first compound to improve the health of diseased upper motor neurons
Read More
Transgene expands trial of TG-4001 with avelumab in HPV-positive anogenital tumors
Read More
Novel autologous immune cell-based therapy shows promise in models of NASH
Read More
New phase I trial evaluates ST-266 in patients with COVID-19
Read More
Placental mesenchymal stem cells studied for in utero repair of myelomeningocele
Read More
ROH-201 enters phase IIa study in dry eye disease
Read More
Kintor reports reduced mortality with proxalutamide in hospitalized COVID-19 patients
Read More